S&P Biotech SPDR (XBI)
$90.87
0.49 (0.54%)
XBI Stock Quote Delayed 30 Minutes
First-Mover Advantage Will Benefit Amarin Stock More Than You Think
There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
68.47M
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
4.68M
Day's Range
$90.54 - $92.18
52-Week Range
$63.80 - $103.52
Dividend & Yield
$0.003 (0.00%)
XBI Stock Predictions, Articles, and S&P Biotech SPDR News
7 Biotech ETFs That Should Remain Healthy
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
Nasdaq Today: iQiyi Surges on Award; Intel, Cisco Struggle
Memory stocks like Micron and semiconductor stocks like AMD were on the move in the Nasdaq today. Intel and Cisco weren't so lucky though.
IBB is up Over 5%, But the Market May Retest its Lows
This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
Biotech ETFs Are the Best Way to Play the Recovering Sector
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock
XBI can profit from full drug pipelines, an improving regulatory climate, high short interest and strengthening technicals.
Bet on Biogen Inc for Easy Profits Into the New Year
Biotech stocks are scary when they are falling. Sell downside risk into BIIB stock support with confidence for a chance at free profits.
Gilead Sciences, Inc. (GILD) Stock Got Its Mojo Back
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead.
Buy Allergan plc Ordinary Shares (AGN) Stock and Don’t Look Back!
Pharma stocks like Allergan scare most investors out of trading them when they fall. Sell AGN puts with a big buffer for easy profits.
SPDR S&P Biotech (ETF) (XBI): The Quick Guide to XBI
Biotechnology investors have turned the equal-weight SPDR S&P Biotech ETF (XBI) into one of the largest sector plays. Is it right for you?
The Move in SPDR S&P Biotech (ETF) (XBI) ETF Is Coming — Get on Board
The biotech trade is always a momentum bet, and currently Wall Street is betting it will go up. I can use this play in XBI for free income.
